Analyst Ratings for Opendoor Technologies
Within the last quarter, Opendoor Technologies (NASDAQ:OPEN) has observed the following analyst ratings:
Keybanc Initiates Coverage On Opendoor Technologies with Sector Weight Rating
Keybanc analyst Justin Patterson initiates coverage on Opendoor Technologies (NASDAQ:OPEN) with a Sector Weight rating.
Alibaba, Zoom Video And 76 Biggest Movers From Yesterday
Gainers
Kaspien Holdings Inc. (NASDAQ: KSPN) shares climbed 161.9% to close at $6.81 on Monday on heavy volume amid mention of the stock on social media.
Why These Casino Stocks Are Moving Lower, Here’s 45 Stocks Moving In Monday’s Mid-Day Session
Gainers
Pliant Therapeutics, Inc. (NASDAQ: PLRX) jumped 112.6% to $18.88 after the company said its treatment for Idiopathic Pulmonary Fibrosis was well tolerated in a Phase 2a study.
Why U.S. Stocks Are Trading Higher Ahead Of Fed Minutes
U.S. stocks traded slightly higher this morning, with the Dow Jones gaining more than 50 points on Wednesday. Investors are awaiting minutes from the recent Federal Reserve meeting.
63 Biggest Movers From Yesterday
Gainers
Advent Technologies Holdings, Inc. (NYSE: ADN) shares surged 244% to close at $3.99 on Thursday after the company announced it received notification of euro 782.1 million of funding from the Greek State for the IPCEI Green HiPo project.
91 Biggest Movers From Friday
Gainers
RISE Education Cayman Ltd (NYSE: REDU) shares jumped 138.5% to settle at $3.41 on Friday. RISE Education announced expected timing for the completion of the merger with Dada Auto.
JMP Securities Initiates Coverage On Opendoor Technologies with Market Outperform Rating, Announces Price Target of $12
JMP Securities analyst Nicholas Jones initiates coverage on Opendoor Technologies (NASDAQ:OPEN) with a Market Outperform rating and announces Price Target of $12.
70 Biggest Movers From Friday
Gainers
Avadel Pharmaceuticals plc (NASDAQ: AVDL) shares climbed 133.6% to close at $2.50 on Friday. Avadel Pharmaceuticals shares dipped 68% on Thursday after announcing new FDA request for experimental narcolepsy drug.